5.70MMarket Cap-61P/E (TTM)
1.890High1.810Low13.44KVolume1.890Open1.840Pre Close24.55KTurnover0.47%Turnover RatioLossP/E (Static)3.12MShares39.48052wk High0.51P/B5.27MFloat Cap1.76052wk Low--Dividend TTM2.88MShs Float3417.576Historical High--Div YieldTTM4.35%Amplitude1.760Historical Low1.826Avg Price1Lot Size
Intelligent Bio Solutions Stock Forum
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(K) Pharmacokinetic (Pk) Study for Its Intelligent Fingerprinting Drug Screening Technology
Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology
Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) Study
Intelligent Bio Solutions (Nasdaq: INBS) has successfully recruited subjects and begun screening for its pharmacokinetic (PK) study, a important step in obtaining FDA 510(k) clearance. This study will enhance the understanding of opiate metabolism, distribution, and excretion in human sweat by comparing results from fingerpri...
2 MINUTES AGO, 8:30 AM EDT
VIA GLOBENEWSWIRE
Dow Jones· 2 mins ago
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights
Year-over-year revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024
Cash and cash equivalents as of March 31, 2024, was $...
No comment yet